Matricelf Ltd. Logo

Matricelf Ltd.

Develops personalized 3D neural implants from patient cells to treat spinal cord injuries.

MTLF | TA

Overview

Corporate Details

ISIN(s):
IL0011767915
LEI:
Country:
Israel
Address:
3 Golda Meir Street, 7651713 Ness Zion
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Matricelf is a preclinical-stage biotechnology company specializing in personalized regenerative medicine. The company develops a proprietary platform for autologous 3D tissue engineering, which creates functional neural implants from a patient's own cells. The technology combines induced Pluripotent Stem Cells (iPSCs) with a personalized hydrogel derived from the patient's extracellular matrix (ECM). This approach is designed to create fully compatible, engineered tissues that promote regeneration without the risk of immune rejection. Matricelf's primary focus is on developing a one-time, curative solution for spinal cord injuries, with its platform also holding potential for treating other conditions such as stroke, traumatic brain injury, and myocardial infarction.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-09-08 20:40
Investor Presentation
COMPANY'S PRESENTATION
Hebrew (modern) 2.3 MB
2024-09-08 20:40
Pre-Annual General Meeting Information
COMPANY'S PRESENTATION
Russian 42.8 KB
2024-03-27 15:30
Investor Presentation
INVESTORS PRESENTATION
English 2.7 MB
2024-03-27 15:30
Pre-Annual General Meeting Information
INVESTORS PRESENTATION
Russian 43.3 KB
2023-02-14 16:31
Investor Presentation
Corporate Presentation - February2023
English 1.1 MB
2023-02-14 16:31
Regulatory News Service
Corporate Presentation - February2023
Russian 42.7 KB
2022-03-16 10:59
Investor Presentation
INVESTORS PRESENTATION
English 2.7 MB
2022-03-16 10:59
Pre-Annual General Meeting Information
INVESTORS PRESENTATION
Russian 41.6 KB
2021-06-17 18:14
Regulatory News Service
Opening of Trading On Sunday June 20, 2021, Appointment of a Market Maker
Hebrew (modern) 256.5 KB
2021-06-14 14:20
Regulatory News Service
Identifying Details of New Security: MATRICELF, MATRICELF.W1
Hebrew (modern) 177.2 KB

Automate Your Workflow. Get a real-time feed of all Matricelf Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Matricelf Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Matricelf Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AGIOS PHARMACEUTICALS, INC. Logo
Pioneering cellular metabolism therapies for rare, genetically defined diseases like anemias.
United States of America AGIO
AIM ImmunoTech Inc. Logo
Develops immuno-therapeutics for cancers, immune disorders, and viral diseases.
United States of America AIM
AKANDA CORP. Logo
Cultivates and distributes pharma-quality medical cannabis for patients in legal markets worldwide.
United States of America AKAN
Akari Therapeutics Plc Logo
A clinical-stage oncology company developing next-gen ADCs for targeted cancer therapy.
United States of America AKTX
Akebia Therapeutics, Inc. Logo
Developing and commercializing novel, FDA-approved therapeutics for kidney disease.
United States of America AKBA
Akero Therapeutics, Inc. Logo
A clinical-stage biotech developing therapies for serious metabolic diseases like MASH.
United States of America AKRO
Alaunos Therapeutics, Inc. Logo
Developing TCR-T cell therapies to treat solid tumors by targeting specific cancer mutations.
United States of America TCRT
Aldeyra Therapeutics, Inc. Logo
Biotech developing therapies for ocular and systemic immune-mediated inflammation.
United States of America ALDX
Alector, Inc. Logo
Pioneers immuno-neurology therapies for neurodegenerative diseases like Alzheimer's.
United States of America ALEC
Aligos Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel oral therapies for liver and viral diseases.
United States of America ALGS

Talk to a Data Expert

Have a question? We'll get back to you promptly.